Assignee
AVALYN PHARMA INC
US·12 granted patents·11 pending applications·36 citations·filing 2013–2025
Top patents by PatentIndex Score
23 records- 0196US11559520B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2020·Granted Jan 24, 2023·4 cites·14 claims
- 0295US11452718B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2020·Granted Sep 27, 2022·3 cites·15 claims
- 0395US10610536B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2018·Granted Apr 7, 2020·5 cites·13 claims
- 0494US11071741B2Aerosol pirfenidone and pyridone analog compound and uses thereofAVALYN PHARMA INC·Filed 2020·Granted Jul 27, 2021·3 cites·15 claims
- 0593US10105356B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2013·Granted Oct 23, 2018·8 cites·14 claims
- 0692US10028966B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2017·Granted Jul 24, 2018·8 cites·13 claims
- 0787US11980689B2Inhaled imatinib for treatment of pulmonary arterial hypertension (PAH)AVALYN PHARMA INC·Filed 2020·Granted May 14, 2024·1 cites·12 claims
- 0887US2025114376A1Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2024·Application pending·0 cites
- 0985US11224592B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2018·Granted Jan 18, 2022·3 cites·10 claims
- 1085US2025090463A1Inhaled imatinib for treatment of pulmonary arterial hypertension (pah)AVALYN PHARMA INC·Filed 2024·Application pending·0 cites
- 1184US11123290B2Specially formulated compositions of inhaled nintedanib and nintedanib saltsAVALYN PHARMA INC·Filed 2019·Granted Sep 21, 2021·1 cites·16 claims
- 1281US2025025415A1Specially formulated compositions of inhaled nintedanib and nintedanib saltsAVALYN PHARMA INC·Filed 2024·Application pending·0 cites
- 1377US12023342B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2021·Granted Jul 2, 2024·0 cites·8 claims
- 1477US2025268821A1Nintedanib and nintedanib combination dry powder compositions and usesAVALYN PHARMA INC·Filed 2024·Application pending·0 cites
- 1577US2025177294A1Nintedanib and nintedanib combination dry powder compositions and usesAVALYN PHARMA INC·Filed 2024·Application pending·0 cites
- 1675US12226407B2Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2023·Granted Feb 18, 2025·0 cites·14 claims
- 1775US2022087937A1Aerosol tyrosine kinase inhibitor compounds and uses thereofAVALYN PHARMA INC·Filed 2021·Application pending·0 cites
- 1874US12090225B2Specially formulated compositions of inhaled nintedanib and nintedanib saltsAVALYN PHARMA INC·Filed 2021·Granted Sep 17, 2024·0 cites·23 claims
- 1971US2019054076A1Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2018·Application pending·0 cites
- 2070US2022218683A1Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2022·Application pending·0 cites
- 2169US2023201487A1Nebulizer device optimization for improved aerosol parameters and uses thereofAVALYN PHARMA INC·Filed 2023·Application pending·0 cites
- 2263US2023330357A1Nebulizer device optimization for improved aerosol parameters and uses thereofAVALYN PHARMA INC·Filed 2021·Application pending·0 cites
- 2362US2025367178A1Aerosol pirfenidone and pyridone analog compounds and uses thereofAVALYN PHARMA INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →